• Reprodctive

    Genetic Testing for all your infertility issues
  • Cancer
    Genetic Testing

    Risk Assesment, Tumour Profiling and Liquid Biopsy
  • Daisy
    Non-Invasive Prenatal TestingTM

    For a peace of Mind

Welcome To Reproductive Genetics & Cancer Solutions

RGCS is one of the premium Next Generation Sequencing (NGS)-based genomics company in India. It is dedicated in providing molecular diagnostic solutions in the domains of Reproductive Genetics, Cancer Genetics, and Pharmacgenomics for personalised medicine to drive the next generation precision medicine.

Our Main Services

Daisy Prenatal TestingTM

Available for Pregnan Moms from 10 weeks of Gestation, with Zero risk of Miscarriage

Double Marker Test

Modern methods of biochemical analysis, especially in combination with genetic and biomarker testing, are able to provide a comprehensive answer to reveal early the cause of a disease.

Preimplantation Genetic Testing

Pre-implantation Genetic Screening and Preimplantation Genetic Diagnosis

Prenatal Diagnosis

Fetal invasive procedures for genetic testing, Chrosome analysis from chorionic villus sampling (CVS)

Cancer Genetic Testing

Various gene sequencing panels that target cancer hotspots, indels, CNVs


Karyotyping to R/O, Klinefelter syndrome, Turner syndrome, Xxy syndrome, Y chromosome, microdeletion testing.

Recurrent Pregnancy Loss

Chrom analysis frpm product of conception for recurrent loss pregnancy.


The shore hat this group would some how form a family all trouble with the law sinced a the day what might be right.

Genetic Counselling

The shore hat this group would some how form a family all trouble with the law sinced a the day what might be right.

Complete NGS Sequencing Solutions


RGCS uses the latest and fastest DNA analysis technology to diagnose complex genetic disorders. The complete bench of all new Ion Semi-conductor based next-generation sequencers (NGS) in our lab gives unmatched speed, affordability and accuracy required for all your molecular genetic testing. Automised robotic workflows with Ion Chef System provides consistant Quality.

More Services


BRCAChekTM is a next-generation sequencing test that looks for abnormal variants in BRCA1 and BRCA2 genes. Detection of abnormal variants in either BRCA1 or BRCA2 gene significantly increases a patient's risk for breast and or ovarian cancer in females and prostate cancer in males.


10% of all prostate cancers are hereditary, meaning that an increased risk for the disease runs in the family. This next-generation sequencing test offered for men with, or at risk of prostate cancer. Test looks for abnormal variants in BRCA1, BRCA2, HOXB13, MLH1, MSH2, MSH6, PMS2 and EPCAM genes.


ColoChekTM is an NGS based Next generation Genetics test method that analyses 11 high-risk colorectal cancer genes ( EPCAM, MLH1, MSH2, MSH6, PMS2, MUTYH, APC, BMPR1A, SMAD4, PTEN and STK11) to determine genetic predisposition for the disease. Perfomred on a blood sample.